Enzon Pharmaceuticals Inc

ENZN

$0.50

+196.7% (1 year change)

Market Cap

$38.5 Million

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$0.02 - $0.85

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-19.04x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $38.5 Million
Enterprise Value -$9.65 Million
Dividend Yield $0.00 (0.0%)
1 Year Return +196.7%
52-Week High $0.85
52-Week Low $0.02
Beta 0.0
Outstanding Shares 74.2 Million
Avg 30 Day Volume 46.7 Thousand

Valuation

P/E Ratio -19.04
PEG -18.21
Earnings per Share -$0.03
Price to Sales Ratio Infinity
Price to Book Ratio Infinity
Revenue to Enterprise Value -22.38
EBIT to Enterprise Value 9.15
Total Debt to Enterprise Value -0.0
Debt to Equity 0.0

Profitability

Revenue $431 Thousand
Gross Profit $431 Thousand
EBIT -$1.05 Million
Net Income -$2.02 Million
Profit Margin -469.61%
Quarterly Earnings Growth (YoY) +104.5%
Return on Equity -4.23%
Return on Assets -4.19%
Return on Invested Capital -2.2%

Enzon Pharmaceuticals Inc

Enzon Pharmaceuticals, Inc is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties.

News

PEGylated Proteins Market 2021: Future Trends, Key Players: ENZON Pharmaceuticals,Merck Sharp & Dohme and others

PEGylated Proteins Market 2021: Future Trends, Key Players: ENZON Pharmaceuticals,Merck Sharp & Dohme and others

Global Info Research offers an overarching research and analysis-based study on, Global PEGylated Proteins Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026. The PEGylat...

Jumbo News Jumbo News, 7 days ago